National Research, Development

National Research & Development (NRD) is a biotechnology and medical device company focused on developing innovative solutions for metabolic disorders and advanced wound care. The company specializes in the formulation of stabilized proteins and small molecules, particularly targeting the Glucagon-like peptide 1 receptor for the treatment of Type 2 diabetes and obesity. NRD also develops proprietary medical devices and topical treatments designed to accelerate tissue repair and manage chronic wounds. By bridging the gap between early-stage research and commercial application, the company aims to provide cost-effective and highly efficacious therapies for global health challenges.